DEBx Medical Opens Office in US

Exiting things are happening at DEBx Medical, and we want to share some important news with you. We are proud to announce that, despite the COVID-19 pandemic, we are starting a new chapter for DEBx Medical by opening our first office in the US: DEBx Medical USA Inc.

Now that our first product, DEBRICHEM, is nearing CE approval, we will focus on getting the FDA approval to enter the US market too. Besides that, from our new location we will also be able to better serve other areas, such as Central and Latin America and Canada.

We are very much looking forward to expanding our team in the US and seeing what opportunities this will bring us. Curious about the possibilities to strengthen our team? We are always looking for exceptional talent to bring this product to the market.

More Posts

In Depth: Debridement

The presence of a biofilm in a wound is known to be detrimental to wound healing as is the case with the presence of necrosis

In Depth: Biofilms

Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what

Biofilms and Antibiotic Resistance

In these times of fewer conventions, congresses, and scientific meetings the world is luckily still continuing scientific research and publishing their results. A group of

Get in touch


Login to get access to our case reports.


Login to your account